Taco Bell’s new 120-milligram energy drinks fill the gap between green-tea refrescas and Rockstar so ordinary stores can sell an afternoon cup.
Bristol Myers ended its Cellares Cell Shuttle pact over commercial Breyanzi, even as autoimmune programs still use the machines.
Two August rules now block visa-free work by Colombians, Georgians and Venezuelans, closing a hiring path that had become a top source of permits.